Facundo Zaffaroni Selected Research

Fatigue

1/2020	Health-related quality of life before and during chemotherapy in patients with early-stage breast cancer.
1/2020	Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Facundo Zaffaroni Research Topics

Disease

7	Neoplasms (Cancer) 06/2022 - 01/2018
4	Breast Neoplasms (Breast Cancer) 10/2020 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 01/2018
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2022 - 01/2020
2	Fatigue 01/2020 - 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Nausea 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Stomatitis 01/2020
1	Rupture 01/2020
1	Vomiting 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Weight Gain 05/2019
1	Adenocarcinoma 05/2019
1	Osteoporosis 05/2019
1	Prostatic Neoplasms (Prostate Cancer) 05/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019

Drug/Important Bio-Agent (IBA)

2	cabozantinibIBA 06/2022 - 01/2020
2	Phenobarbital (Luminal)FDA Link 10/2020 - 11/2019
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2020
1	LigandsIBA 11/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	ORALIT (ORS)IBA 10/2019
1	apalutamideIBA 05/2019
1	Abiraterone AcetateIBA 05/2019
1	Testosterone (Sustanon)FDA Link 05/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2020 - 05/2019
1	Radiotherapy 01/2022
1	Neoadjuvant Therapy 01/2022
1	Drug Tapering 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Castration 05/2019
1	Consolidation Chemotherapy 01/2018